Hispana. Acceso en línea al Patrimonio Cultural Digital Español

Está en:  › Datos de registro

A compendium answering 150 questions on COVID-19 and SARS-CoV-2.

Identificadores del recurso

0105-4538

http://hdl.handle.net/10641/2322

10.1111/all.14449

Procedencia

(Repositorio Institucional de la Universidad Francisco de Vitoria)

Ficha

Título:: A compendium answering 150 questions on COVID-19 and SARS-CoV-2.
Tema:: Allergy; Coronavirus disease 2019; COVID-19; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus 2
Descripción:: In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.; post-print; 2,59 MB
Idioma:: English
Relación:: https://onlinelibrary.wiley.com/doi/10.1111/all.14449
Autor/Productor:: Riggioni, Carmen; Comberiati, Pasquale; Giovannini, Mattia; Agache, Ioana; Akdis, Mübeccel; Alves-Correia, Magna; Antó, Josep M.; Arcolaci, Alessandra; Azkur, Ahmet Kursat; Azkur, Dilek; Beken, Burcin; Boccabella, Cristina; Bousquet, Jean; Breiteneder, Heimo; Carvalho, Daniela; De las Vecillas, Leticia; Diamant, Zuzana; Eguiluz-Gracia, Ibon; Eiwegger, Thomas; Eyerich, Stefanie; Fokkens, Wytske; Gao, Ya-dong; Hannachi, Farah; Johnston, Sebastian L.; Jutel, Marek; Karavelia, Aspasia; Klimek, Ludger; Moya, Beatriz; Nadeau, Kari C.; O'Hehir, Robyn; O'Mahony, Liam; Pfaar, Oliver; Sanak, Marek; Schwarze, Jürgen; Sokolowska, Milena; Torres, María J.; Van de Veen, Willem; Van Zelm, Menno C.; Wang, De Yun; Zhang, Luo; Jiménez-Saiz, Rodrigo; Akdis, Cezmi A.
Editor:: Allergy
Derechos:: Atribución-NoComercial-SinDerivadas 3.0 España; http://creativecommons.org/licenses/by-nc-nd/3.0/es/; openAccess
Fecha:: 2021-06-15T10:39:50Z; 2020
Tipo de recurso:: article

oai_dc

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
1. <dc:title>A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</dc:title>
2. <dc:creator>Riggioni, Carmen</dc:creator>
3. <dc:creator>Comberiati, Pasquale</dc:creator>
4. <dc:creator>Giovannini, Mattia</dc:creator>
5. <dc:creator>Agache, Ioana</dc:creator>
6. <dc:creator>Akdis, Mübeccel</dc:creator>
7. <dc:creator>Alves-Correia, Magna</dc:creator>
8. <dc:creator>Antó, Josep M.</dc:creator>
9. <dc:creator>Arcolaci, Alessandra</dc:creator>
10. <dc:creator>Azkur, Ahmet Kursat</dc:creator>
11. <dc:creator>Azkur, Dilek</dc:creator>
12. <dc:creator>Beken, Burcin</dc:creator>
13. <dc:creator>Boccabella, Cristina</dc:creator>
14. <dc:creator>Bousquet, Jean</dc:creator>
15. <dc:creator>Breiteneder, Heimo</dc:creator>
16. <dc:creator>Carvalho, Daniela</dc:creator>
17. <dc:creator>De las Vecillas, Leticia</dc:creator>
18. <dc:creator>Diamant, Zuzana</dc:creator>
19. <dc:creator>Eguiluz-Gracia, Ibon</dc:creator>
20. <dc:creator>Eiwegger, Thomas</dc:creator>
21. <dc:creator>Eyerich, Stefanie</dc:creator>
22. <dc:creator>Fokkens, Wytske</dc:creator>
23. <dc:creator>Gao, Ya-dong</dc:creator>
24. <dc:creator>Hannachi, Farah</dc:creator>
25. <dc:creator>Johnston, Sebastian L.</dc:creator>
26. <dc:creator>Jutel, Marek</dc:creator>
27. <dc:creator>Karavelia, Aspasia</dc:creator>
28. <dc:creator>Klimek, Ludger</dc:creator>
29. <dc:creator>Moya, Beatriz</dc:creator>
30. <dc:creator>Nadeau, Kari C.</dc:creator>
31. <dc:creator>O'Hehir, Robyn</dc:creator>
32. <dc:creator>O'Mahony, Liam</dc:creator>
33. <dc:creator>Pfaar, Oliver</dc:creator>
34. <dc:creator>Sanak, Marek</dc:creator>
35. <dc:creator>Schwarze, Jürgen</dc:creator>
36. <dc:creator>Sokolowska, Milena</dc:creator>
37. <dc:creator>Torres, María J.</dc:creator>
38. <dc:creator>Van de Veen, Willem</dc:creator>
39. <dc:creator>Van Zelm, Menno C.</dc:creator>
40. <dc:creator>Wang, De Yun</dc:creator>
41. <dc:creator>Zhang, Luo</dc:creator>
42. <dc:creator>Jiménez-Saiz, Rodrigo</dc:creator>
43. <dc:creator>Akdis, Cezmi A.</dc:creator>
44. <dc:subject>Allergy</dc:subject>
45. <dc:subject>Coronavirus disease 2019</dc:subject>
46. <dc:subject>COVID-19</dc:subject>
47. <dc:subject>SARS-CoV-2</dc:subject>
48. <dc:subject>Severe acute respiratory syndrome-related coronavirus 2</dc:subject>
49. <dc:description>In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</dc:description>
50. <dc:description>post-print</dc:description>
51. <dc:description>2,59 MB</dc:description>
52. <dc:date>2021-06-15T10:39:50Z</dc:date>
53. <dc:date>2021-06-15T10:39:50Z</dc:date>
54. <dc:date>2020</dc:date>
55. <dc:type>article</dc:type>
56. <dc:identifier>0105-4538</dc:identifier>
57. <dc:identifier>http://hdl.handle.net/10641/2322</dc:identifier>
58. <dc:identifier>10.1111/all.14449</dc:identifier>
59. <dc:language>eng</dc:language>
60. <dc:relation>https://onlinelibrary.wiley.com/doi/10.1111/all.14449</dc:relation>
61. <dc:rights>Atribución-NoComercial-SinDerivadas 3.0 España</dc:rights>
62. <dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights>
63. <dc:rights>openAccess</dc:rights>
64. <dc:publisher>Allergy</dc:publisher>
</oai_dc:dc>

didl

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<d:DIDL schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
1. <d:DIDLInfo>
  1. <dcterms:created schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2021-06-15T10:39:50Z</dcterms:created>
  </d:DIDLInfo>
2. <d:Item id="hdl_10641_2322">
  1. <d:Descriptor>
    1. <d:Statement mimeType="application/xml; charset=utf-8">
      1. <dii:Identifier schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10641/2322</dii:Identifier>
      </d:Statement>
    </d:Descriptor>
  2. <d:Descriptor>
    1. <d:Statement mimeType="application/xml; charset=utf-8">
      1. <oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
        <dc:title>A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</dc:title>
        <dc:creator>Riggioni, Carmen</dc:creator>
        <dc:creator>Comberiati, Pasquale</dc:creator>
        <dc:creator>Giovannini, Mattia</dc:creator>
        <dc:creator>Agache, Ioana</dc:creator>
        <dc:creator>Akdis, Mübeccel</dc:creator>
        <dc:creator>Alves-Correia, Magna</dc:creator>
        <dc:creator>Antó, Josep M.</dc:creator>
        <dc:creator>Arcolaci, Alessandra</dc:creator>
        <dc:creator>Azkur, Ahmet Kursat</dc:creator>
        <dc:creator>Azkur, Dilek</dc:creator>
        <dc:creator>Beken, Burcin</dc:creator>
        <dc:creator>Boccabella, Cristina</dc:creator>
        <dc:creator>Bousquet, Jean</dc:creator>
        <dc:creator>Breiteneder, Heimo</dc:creator>
        <dc:creator>Carvalho, Daniela</dc:creator>
        <dc:creator>De las Vecillas, Leticia</dc:creator>
        <dc:creator>Diamant, Zuzana</dc:creator>
        <dc:creator>Eguiluz-Gracia, Ibon</dc:creator>
        <dc:creator>Eiwegger, Thomas</dc:creator>
        <dc:creator>Eyerich, Stefanie</dc:creator>
        <dc:creator>Fokkens, Wytske</dc:creator>
        <dc:creator>Gao, Ya-dong</dc:creator>
        <dc:creator>Hannachi, Farah</dc:creator>
        <dc:creator>Johnston, Sebastian L.</dc:creator>
        <dc:creator>Jutel, Marek</dc:creator>
        <dc:creator>Karavelia, Aspasia</dc:creator>
        <dc:creator>Klimek, Ludger</dc:creator>
        <dc:creator>Moya, Beatriz</dc:creator>
        <dc:creator>Nadeau, Kari C.</dc:creator>
        <dc:creator>O'Hehir, Robyn</dc:creator>
        <dc:creator>O'Mahony, Liam</dc:creator>
        <dc:creator>Pfaar, Oliver</dc:creator>
        <dc:creator>Sanak, Marek</dc:creator>
        <dc:creator>Schwarze, Jürgen</dc:creator>
        <dc:creator>Sokolowska, Milena</dc:creator>
        <dc:creator>Torres, María J.</dc:creator>
        <dc:creator>Van de Veen, Willem</dc:creator>
        <dc:creator>Van Zelm, Menno C.</dc:creator>
        <dc:creator>Wang, De Yun</dc:creator>
        <dc:creator>Zhang, Luo</dc:creator>
        <dc:creator>Jiménez-Saiz, Rodrigo</dc:creator>
        <dc:creator>Akdis, Cezmi A.</dc:creator>
        <dc:subject>Allergy</dc:subject>
        <dc:subject>Coronavirus disease 2019</dc:subject>
        <dc:subject>COVID-19</dc:subject>
        <dc:subject>SARS-CoV-2</dc:subject>
        <dc:subject>Severe acute respiratory syndrome-related coronavirus 2</dc:subject>
        <dc:description>In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</dc:description>
        <dc:date>2021-06-15T10:39:50Z</dc:date>
        <dc:date>2021-06-15T10:39:50Z</dc:date>
        <dc:date>2020</dc:date>
        <dc:type>article</dc:type>
        <dc:identifier>0105-4538</dc:identifier>
        <dc:identifier>http://hdl.handle.net/10641/2322</dc:identifier>
        <dc:identifier>10.1111/all.14449</dc:identifier>
        <dc:language>eng</dc:language>
        <dc:relation>https://onlinelibrary.wiley.com/doi/10.1111/all.14449</dc:relation>
        <dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights>
        <dc:rights>openAccess</dc:rights>
        <dc:rights>Atribución-NoComercial-SinDerivadas 3.0 España</dc:rights>
        <dc:publisher>Allergy</dc:publisher>
        </oai_dc:dc>
      </d:Statement>
    </d:Descriptor>
  3. <d:Component id="10641_2322_1">
    1. <d:Resource mimeType="application/pdf" ref="http://ddfv.ufv.es/bitstream/10641/2322/1/all.14449.pdf" />
    </d:Component>
  </d:Item>
</d:DIDL>

dim

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<dim:dim schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
1. <dim:field authority="1f3cd91c-9e10-4a07-870c-a30a7d02e74b" confidence="600" element="contributor" mdschema="dc" qualifier="author">Riggioni, Carmen</dim:field>
2. <dim:field authority="ee4f6d96-51a5-4c1f-8953-5f3ec4b57e02" confidence="600" element="contributor" mdschema="dc" qualifier="author">Comberiati, Pasquale</dim:field>
3. <dim:field authority="4bd0c581-c561-451a-b392-d0874db75db9" confidence="600" element="contributor" mdschema="dc" qualifier="author">Giovannini, Mattia</dim:field>
4. <dim:field authority="09de94e0-8daa-4c6f-81b4-cc207418ff74" confidence="600" element="contributor" mdschema="dc" qualifier="author">Agache, Ioana</dim:field>
5. <dim:field authority="69412ee0-4967-4c5f-a732-9d7431c9d221" confidence="600" element="contributor" mdschema="dc" qualifier="author">Akdis, Mübeccel</dim:field>
6. <dim:field authority="1bd1619b-36d8-41d3-b058-ecbaa3b5676e" confidence="600" element="contributor" mdschema="dc" qualifier="author">Alves-Correia, Magna</dim:field>
7. <dim:field authority="c74b2ce6-2855-4dd8-bf22-7d6243cb4bb7" confidence="600" element="contributor" mdschema="dc" qualifier="author">Antó, Josep M.</dim:field>
8. <dim:field authority="ab467e8b-c6c8-4017-ac81-a374ceb4bd5b" confidence="600" element="contributor" mdschema="dc" qualifier="author">Arcolaci, Alessandra</dim:field>
9. <dim:field authority="e10531c7-43d5-43d5-b940-283ce608e2f4" confidence="600" element="contributor" mdschema="dc" qualifier="author">Azkur, Ahmet Kursat</dim:field>
10. <dim:field authority="a643501e-43d3-4314-b8df-df131a20c0dc" confidence="600" element="contributor" mdschema="dc" qualifier="author">Azkur, Dilek</dim:field>
11. <dim:field authority="7d78f2c1-cae2-4c49-8fd2-27b70a938746" confidence="600" element="contributor" mdschema="dc" qualifier="author">Beken, Burcin</dim:field>
12. <dim:field authority="8268f781-d7e0-48b0-b04e-21f06947d8b1" confidence="600" element="contributor" mdschema="dc" qualifier="author">Boccabella, Cristina</dim:field>
13. <dim:field authority="478904c2-695f-4832-b5a4-a5492f2f4017" confidence="600" element="contributor" mdschema="dc" qualifier="author">Bousquet, Jean</dim:field>
14. <dim:field authority="25f637ac-1cdd-4fa3-9096-8a7f18144470" confidence="600" element="contributor" mdschema="dc" qualifier="author">Breiteneder, Heimo</dim:field>
15. <dim:field authority="b69efa5c-e57d-427d-8928-11d3e5bc1c4f" confidence="600" element="contributor" mdschema="dc" qualifier="author">Carvalho, Daniela</dim:field>
16. <dim:field authority="6fa0b071-7ffb-4779-a2ad-da564a0b21bd" confidence="600" element="contributor" mdschema="dc" qualifier="author">De las Vecillas, Leticia</dim:field>
17. <dim:field authority="3b9ea73e-a35e-480a-8afe-c368a18dea5e" confidence="600" element="contributor" mdschema="dc" qualifier="author">Diamant, Zuzana</dim:field>
18. <dim:field authority="d17f943d-9c05-4c07-bdec-d9a604edec52" confidence="600" element="contributor" mdschema="dc" qualifier="author">Eguiluz-Gracia, Ibon</dim:field>
19. <dim:field authority="6deb7e44-67a2-4922-afbb-cd09ce0a2896" confidence="600" element="contributor" mdschema="dc" qualifier="author">Eiwegger, Thomas</dim:field>
20. <dim:field authority="493091ae-31cb-4c04-9905-62411aec73fd" confidence="600" element="contributor" mdschema="dc" qualifier="author">Eyerich, Stefanie</dim:field>
21. <dim:field authority="1328cfb8-b64c-4bec-824b-39a49a707542" confidence="600" element="contributor" mdschema="dc" qualifier="author">Fokkens, Wytske</dim:field>
22. <dim:field authority="8981f3db-c05b-466e-9c01-169cdca39d60" confidence="600" element="contributor" mdschema="dc" qualifier="author">Gao, Ya-dong</dim:field>
23. <dim:field authority="a6c524aa-4248-40ed-b4b7-91c1e930afbe" confidence="600" element="contributor" mdschema="dc" qualifier="author">Hannachi, Farah</dim:field>
24. <dim:field authority="e3911610-4d90-4798-9653-db6760124fa0" confidence="600" element="contributor" mdschema="dc" qualifier="author">Johnston, Sebastian L.</dim:field>
25. <dim:field authority="33d62bae-7001-4ce3-bd00-f0edf123bc80" confidence="600" element="contributor" mdschema="dc" qualifier="author">Jutel, Marek</dim:field>
26. <dim:field authority="8e05c3f9-3736-457f-82d9-b4fbe70a8efb" confidence="600" element="contributor" mdschema="dc" qualifier="author">Karavelia, Aspasia</dim:field>
27. <dim:field authority="acf05571-4fc5-45c3-92a3-ec1331c9be22" confidence="600" element="contributor" mdschema="dc" qualifier="author">Klimek, Ludger</dim:field>
28. <dim:field authority="4749920d-be53-4f1c-8b55-00b65ed154ca" confidence="600" element="contributor" mdschema="dc" qualifier="author">Moya, Beatriz</dim:field>
29. <dim:field authority="de71bbb8-537a-4451-a128-00f9d2bbbae2" confidence="600" element="contributor" mdschema="dc" qualifier="author">Nadeau, Kari C.</dim:field>
30. <dim:field authority="75705d12-f79e-460f-878e-8660dc049a91" confidence="600" element="contributor" mdschema="dc" qualifier="author">O'Hehir, Robyn</dim:field>
31. <dim:field authority="709e3101-f7eb-4661-b6de-eac110c71bf0" confidence="600" element="contributor" mdschema="dc" qualifier="author">O'Mahony, Liam</dim:field>
32. <dim:field authority="2ad13a86-9e46-4ed0-986c-abb7aecbebb7" confidence="600" element="contributor" mdschema="dc" qualifier="author">Pfaar, Oliver</dim:field>
33. <dim:field authority="75da5432-6a86-43b1-862d-7a41fdac1788" confidence="600" element="contributor" mdschema="dc" qualifier="author">Sanak, Marek</dim:field>
34. <dim:field authority="8253fd73-1b00-47ef-964e-f8db090aafb7" confidence="600" element="contributor" mdschema="dc" qualifier="author">Schwarze, Jürgen</dim:field>
35. <dim:field authority="187d0984-a5dd-48c6-ad10-02807a8cd4dd" confidence="600" element="contributor" mdschema="dc" qualifier="author">Sokolowska, Milena</dim:field>
36. <dim:field authority="87e7160e-f50c-4c14-87db-8e33a65ddd17" confidence="600" element="contributor" mdschema="dc" qualifier="author">Torres, María J.</dim:field>
37. <dim:field authority="3f993b14-1942-4856-bf28-12e9d79242dd" confidence="600" element="contributor" mdschema="dc" qualifier="author">Van de Veen, Willem</dim:field>
38. <dim:field authority="7593d05b-10d4-4534-9ea5-1c7d83a65ef0" confidence="600" element="contributor" mdschema="dc" qualifier="author">Van Zelm, Menno C.</dim:field>
39. <dim:field authority="12096dd1-93cb-4a6f-b0e0-ee41f34308b2" confidence="600" element="contributor" mdschema="dc" qualifier="author">Wang, De Yun</dim:field>
40. <dim:field authority="d326595f-eeb7-42a4-9c74-6ea227398e49" confidence="600" element="contributor" mdschema="dc" qualifier="author">Zhang, Luo</dim:field>
41. <dim:field authority="a6b6771f-0ac3-4a44-ab4e-7862e875d21f" confidence="600" element="contributor" mdschema="dc" qualifier="author">Jiménez-Saiz, Rodrigo</dim:field>
42. <dim:field authority="888fc87b-bf4a-4dd7-8150-bcc5390229a6" confidence="600" element="contributor" mdschema="dc" qualifier="author">Akdis, Cezmi A.</dim:field>
43. <dim:field element="date" mdschema="dc" qualifier="accessioned">2021-06-15T10:39:50Z</dim:field>
44. <dim:field element="date" mdschema="dc" qualifier="available">2021-06-15T10:39:50Z</dim:field>
45. <dim:field element="date" mdschema="dc" qualifier="issued">2020</dim:field>
46. <dim:field element="identifier" lang="spa" mdschema="dc" qualifier="issn">0105-4538</dim:field>
47. <dim:field element="identifier" mdschema="dc" qualifier="uri">http://hdl.handle.net/10641/2322</dim:field>
48. <dim:field element="identifier" lang="spa" mdschema="dc" qualifier="doi">10.1111/all.14449</dim:field>
49. <dim:field element="description" lang="spa" mdschema="dc" qualifier="abstract">In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</dim:field>
50. <dim:field element="description" lang="spa" mdschema="dc" qualifier="version">post-print</dim:field>
51. <dim:field element="description" lang="spa" mdschema="dc" qualifier="extent">2,59 MB</dim:field>
52. <dim:field element="language" lang="spa" mdschema="dc" qualifier="iso">eng</dim:field>
53. <dim:field element="publisher" lang="spa" mdschema="dc">Allergy</dim:field>
54. <dim:field element="rights" lang="*" mdschema="dc">Atribución-NoComercial-SinDerivadas 3.0 España</dim:field>
55. <dim:field element="rights" lang="*" mdschema="dc" qualifier="uri">http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dim:field>
56. <dim:field element="rights" lang="spa" mdschema="dc" qualifier="accessRights">openAccess</dim:field>
57. <dim:field element="subject" lang="spa" mdschema="dc">Allergy</dim:field>
58. <dim:field element="subject" lang="spa" mdschema="dc">Coronavirus disease 2019</dim:field>
59. <dim:field element="subject" lang="spa" mdschema="dc">COVID-19</dim:field>
60. <dim:field element="subject" lang="spa" mdschema="dc">SARS-CoV-2</dim:field>
61. <dim:field element="subject" lang="spa" mdschema="dc">Severe acute respiratory syndrome-related coronavirus 2</dim:field>
62. <dim:field element="title" lang="spa" mdschema="dc">A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</dim:field>
63. <dim:field element="type" lang="spa" mdschema="dc">article</dim:field>
64. <dim:field element="relation" lang="spa" mdschema="dc" qualifier="publisherversion">https://onlinelibrary.wiley.com/doi/10.1111/all.14449</dim:field>
</dim:dim>

etdms

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<thesis schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
1. <title>A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</title>
2. <creator>Riggioni, Carmen</creator>
3. <creator>Comberiati, Pasquale</creator>
4. <creator>Giovannini, Mattia</creator>
5. <creator>Agache, Ioana</creator>
6. <creator>Akdis, Mübeccel</creator>
7. <creator>Alves-Correia, Magna</creator>
8. <creator>Antó, Josep M.</creator>
9. <creator>Arcolaci, Alessandra</creator>
10. <creator>Azkur, Ahmet Kursat</creator>
11. <creator>Azkur, Dilek</creator>
12. <creator>Beken, Burcin</creator>
13. <creator>Boccabella, Cristina</creator>
14. <creator>Bousquet, Jean</creator>
15. <creator>Breiteneder, Heimo</creator>
16. <creator>Carvalho, Daniela</creator>
17. <creator>De las Vecillas, Leticia</creator>
18. <creator>Diamant, Zuzana</creator>
19. <creator>Eguiluz-Gracia, Ibon</creator>
20. <creator>Eiwegger, Thomas</creator>
21. <creator>Eyerich, Stefanie</creator>
22. <creator>Fokkens, Wytske</creator>
23. <creator>Gao, Ya-dong</creator>
24. <creator>Hannachi, Farah</creator>
25. <creator>Johnston, Sebastian L.</creator>
26. <creator>Jutel, Marek</creator>
27. <creator>Karavelia, Aspasia</creator>
28. <creator>Klimek, Ludger</creator>
29. <creator>Moya, Beatriz</creator>
30. <creator>Nadeau, Kari C.</creator>
31. <creator>O'Hehir, Robyn</creator>
32. <creator>O'Mahony, Liam</creator>
33. <creator>Pfaar, Oliver</creator>
34. <creator>Sanak, Marek</creator>
35. <creator>Schwarze, Jürgen</creator>
36. <creator>Sokolowska, Milena</creator>
37. <creator>Torres, María J.</creator>
38. <creator>Van de Veen, Willem</creator>
39. <creator>Van Zelm, Menno C.</creator>
40. <creator>Wang, De Yun</creator>
41. <creator>Zhang, Luo</creator>
42. <creator>Jiménez-Saiz, Rodrigo</creator>
43. <creator>Akdis, Cezmi A.</creator>
44. <subject>Allergy</subject>
45. <subject>Coronavirus disease 2019</subject>
46. <subject>COVID-19</subject>
47. <subject>SARS-CoV-2</subject>
48. <subject>Severe acute respiratory syndrome-related coronavirus 2</subject>
49. <description>In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</description>
50. <date>2021-06-15</date>
51. <date>2021-06-15</date>
52. <date>2020</date>
53. <type>article</type>
54. <identifier>0105-4538</identifier>
55. <identifier>http://hdl.handle.net/10641/2322</identifier>
56. <identifier>10.1111/all.14449</identifier>
57. <language>eng</language>
58. <relation>https://onlinelibrary.wiley.com/doi/10.1111/all.14449</relation>
59. <rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</rights>
60. <rights>openAccess</rights>
61. <rights>Atribución-NoComercial-SinDerivadas 3.0 España</rights>
62. <publisher>Allergy</publisher>
</thesis>

marc

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<record schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
1. <leader>00925njm 22002777a 4500</leader>
2. <datafield ind1=" " ind2=" " tag="042">
  1. <subfield code="a">dc</subfield>
  </datafield>
3. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Riggioni, Carmen</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
4. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Comberiati, Pasquale</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
5. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Giovannini, Mattia</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
6. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Agache, Ioana</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
7. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Akdis, Mübeccel</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
8. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Alves-Correia, Magna</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
9. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Antó, Josep M.</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
10. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Arcolaci, Alessandra</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
11. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Azkur, Ahmet Kursat</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
12. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Azkur, Dilek</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
13. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Beken, Burcin</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
14. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Boccabella, Cristina</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
15. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Bousquet, Jean</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
16. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Breiteneder, Heimo</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
17. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Carvalho, Daniela</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
18. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">De las Vecillas, Leticia</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
19. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Diamant, Zuzana</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
20. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Eguiluz-Gracia, Ibon</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
21. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Eiwegger, Thomas</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
22. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Eyerich, Stefanie</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
23. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Fokkens, Wytske</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
24. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Gao, Ya-dong</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
25. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Hannachi, Farah</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
26. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Johnston, Sebastian L.</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
27. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Jutel, Marek</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
28. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Karavelia, Aspasia</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
29. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Klimek, Ludger</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
30. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Moya, Beatriz</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
31. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Nadeau, Kari C.</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
32. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">O'Hehir, Robyn</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
33. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">O'Mahony, Liam</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
34. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Pfaar, Oliver</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
35. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Sanak, Marek</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
36. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Schwarze, Jürgen</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
37. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Sokolowska, Milena</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
38. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Torres, María J.</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
39. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Van de Veen, Willem</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
40. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Van Zelm, Menno C.</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
41. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Wang, De Yun</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
42. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Zhang, Luo</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
43. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Jiménez-Saiz, Rodrigo</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
44. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Akdis, Cezmi A.</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
45. <datafield ind1=" " ind2=" " tag="260">
  1. <subfield code="c">2020</subfield>
  </datafield>
46. <datafield ind1=" " ind2=" " tag="520">
  1. <subfield code="a">In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</subfield>
  </datafield>
47. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">0105-4538</subfield>
  </datafield>
48. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">http://hdl.handle.net/10641/2322</subfield>
  </datafield>
49. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">10.1111/all.14449</subfield>
  </datafield>
50. <datafield ind1=" " ind2=" " tag="653">
  1. <subfield code="a">Allergy</subfield>
  </datafield>
51. <datafield ind1=" " ind2=" " tag="653">
  1. <subfield code="a">Coronavirus disease 2019</subfield>
  </datafield>
52. <datafield ind1=" " ind2=" " tag="653">
  1. <subfield code="a">COVID-19</subfield>
  </datafield>
53. <datafield ind1=" " ind2=" " tag="653">
  1. <subfield code="a">SARS-CoV-2</subfield>
  </datafield>
54. <datafield ind1=" " ind2=" " tag="653">
  1. <subfield code="a">Severe acute respiratory syndrome-related coronavirus 2</subfield>
  </datafield>
55. <datafield ind1="0" ind2="0" tag="245">
  1. <subfield code="a">A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</subfield>
  </datafield>
</record>

mets

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<mets ID=" DSpace_ITEM_10641-2322" OBJID=" hdl:10641/2322" PROFILE="DSpace METS SIP Profile 1.0" TYPE="DSpace ITEM" schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd">
1. <metsHdr CREATEDATE="2022-09-20T09:21:23Z">
  1. <agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
    1. <name>DDFV</name>
    </agent>
  </metsHdr>
2. <dmdSec ID="DMD_10641_2322">
  1. <mdWrap MDTYPE="MODS">
    1. <xmlData schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
      1. <mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Riggioni, Carmen</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Comberiati, Pasquale</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Giovannini, Mattia</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Agache, Ioana</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Akdis, Mübeccel</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Alves-Correia, Magna</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Antó, Josep M.</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Arcolaci, Alessandra</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Azkur, Ahmet Kursat</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Azkur, Dilek</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Beken, Burcin</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Boccabella, Cristina</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Bousquet, Jean</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Breiteneder, Heimo</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Carvalho, Daniela</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>De las Vecillas, Leticia</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Diamant, Zuzana</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Eguiluz-Gracia, Ibon</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Eiwegger, Thomas</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Eyerich, Stefanie</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Fokkens, Wytske</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Gao, Ya-dong</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Hannachi, Farah</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Johnston, Sebastian L.</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Jutel, Marek</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Karavelia, Aspasia</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Klimek, Ludger</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Moya, Beatriz</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Nadeau, Kari C.</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>O'Hehir, Robyn</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>O'Mahony, Liam</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Pfaar, Oliver</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Sanak, Marek</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Schwarze, Jürgen</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Sokolowska, Milena</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Torres, María J.</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Van de Veen, Willem</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Van Zelm, Menno C.</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Wang, De Yun</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Zhang, Luo</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Jiménez-Saiz, Rodrigo</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Akdis, Cezmi A.</mods:namePart>
        </mods:name>
        <mods:extension>
        <mods:dateAccessioned encoding="iso8601">2021-06-15T10:39:50Z</mods:dateAccessioned>
        </mods:extension>
        <mods:extension>
        <mods:dateAvailable encoding="iso8601">2021-06-15T10:39:50Z</mods:dateAvailable>
        </mods:extension>
        <mods:originInfo>
        <mods:dateIssued encoding="iso8601">2020</mods:dateIssued>
        </mods:originInfo>
        <mods:identifier type="issn">0105-4538</mods:identifier>
        <mods:identifier type="uri">http://hdl.handle.net/10641/2322</mods:identifier>
        <mods:identifier type="doi">10.1111/all.14449</mods:identifier>
        <mods:abstract>In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</mods:abstract>
        <mods:language>
        <mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
        </mods:language>
        <mods:accessCondition type="useAndReproduction">Atribución-NoComercial-SinDerivadas 3.0 España</mods:accessCondition>
        <mods:subject>
        <mods:topic>Allergy</mods:topic>
        </mods:subject>
        <mods:subject>
        <mods:topic>Coronavirus disease 2019</mods:topic>
        </mods:subject>
        <mods:subject>
        <mods:topic>COVID-19</mods:topic>
        </mods:subject>
        <mods:subject>
        <mods:topic>SARS-CoV-2</mods:topic>
        </mods:subject>
        <mods:subject>
        <mods:topic>Severe acute respiratory syndrome-related coronavirus 2</mods:topic>
        </mods:subject>
        <mods:titleInfo>
        <mods:title>A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</mods:title>
        </mods:titleInfo>
        <mods:genre>article</mods:genre>
        </mods:mods>
      </xmlData>
    </mdWrap>
  </dmdSec>
3. <amdSec ID="TMD_10641_2322">
  1. <rightsMD ID="RIG_10641_2322">
    1. <mdWrap MDTYPE="OTHER" MIMETYPE="text/plain" OTHERMDTYPE="DSpaceDepositLicense">
      1. <binData>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</binData>
      </mdWrap>
    </rightsMD>
  </amdSec>
4. <amdSec ID="FO_10641_2322_1">
  1. <techMD ID="TECH_O_10641_2322_1">
    1. <mdWrap MDTYPE="PREMIS">
      1. <xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
        <premis:premis>
        <premis:object>
        <premis:objectIdentifier>
        <premis:objectIdentifierType>URL</premis:objectIdentifierType>
        <premis:objectIdentifierValue>http://ddfv.ufv.es/bitstream/10641/2322/1/all.14449.pdf</premis:objectIdentifierValue>
        </premis:objectIdentifier>
        <premis:objectCategory>File</premis:objectCategory>
        <premis:objectCharacteristics>
        <premis:fixity>
        <premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
        <premis:messageDigest>f885282ebbc51a2d43fb951d61d34f98</premis:messageDigest>
        </premis:fixity>
        <premis:size>2723785</premis:size>
        <premis:format>
        <premis:formatDesignation>
        <premis:formatName>application/pdf</premis:formatName>
        </premis:formatDesignation>
        </premis:format>
        </premis:objectCharacteristics>
        <premis:originalName>all.14449.pdf</premis:originalName>
        </premis:object>
        </premis:premis>
        </xmlData>
      </mdWrap>
    </techMD>
  </amdSec>
5. <amdSec ID="FT_10641_2322_4">
  1. <techMD ID="TECH_T_10641_2322_4">
    1. <mdWrap MDTYPE="PREMIS">
      1. <xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
        <premis:premis>
        <premis:object>
        <premis:objectIdentifier>
        <premis:objectIdentifierType>URL</premis:objectIdentifierType>
        <premis:objectIdentifierValue>http://ddfv.ufv.es/bitstream/10641/2322/4/all.14449.pdf.txt</premis:objectIdentifierValue>
        </premis:objectIdentifier>
        <premis:objectCategory>File</premis:objectCategory>
        <premis:objectCharacteristics>
        <premis:fixity>
        <premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
        <premis:messageDigest>8d3257013c06de42b96b9decb9264253</premis:messageDigest>
        </premis:fixity>
        <premis:size>199857</premis:size>
        <premis:format>
        <premis:formatDesignation>
        <premis:formatName>text/plain</premis:formatName>
        </premis:formatDesignation>
        </premis:format>
        </premis:objectCharacteristics>
        <premis:originalName>all.14449.pdf.txt</premis:originalName>
        </premis:object>
        </premis:premis>
        </xmlData>
      </mdWrap>
    </techMD>
  </amdSec>
6. <fileSec>
  1. <fileGrp USE="ORIGINAL">
    1. <file ADMID="FO_10641_2322_1" CHECKSUM="f885282ebbc51a2d43fb951d61d34f98" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10641_2322_1" ID="BITSTREAM_ORIGINAL_10641_2322_1" MIMETYPE="application/pdf" SEQ="1" SIZE="2723785">
      1. <FLocat LOCTYPE="URL" href="http://ddfv.ufv.es/bitstream/10641/2322/1/all.14449.pdf" type="simple" />
      </file>
    </fileGrp>
  2. <fileGrp USE="TEXT">
    1. <file ADMID="FT_10641_2322_4" CHECKSUM="8d3257013c06de42b96b9decb9264253" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10641_2322_4" ID="BITSTREAM_TEXT_10641_2322_4" MIMETYPE="text/plain" SEQ="4" SIZE="199857">
      1. <FLocat LOCTYPE="URL" href="http://ddfv.ufv.es/bitstream/10641/2322/4/all.14449.pdf.txt" type="simple" />
      </file>
    </fileGrp>
  </fileSec>
7. <structMap LABEL="DSpace Object" TYPE="LOGICAL">
  1. <div ADMID="DMD_10641_2322" TYPE="DSpace Object Contents">
    1. <div TYPE="DSpace BITSTREAM">
      1. <fptr FILEID="BITSTREAM_ORIGINAL_10641_2322_1" />
      </div>
    </div>
  </structMap>
</mets>

mods

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
1. <mods:name>
  1. <mods:namePart>Riggioni, Carmen</mods:namePart>
  </mods:name>
2. <mods:name>
  1. <mods:namePart>Comberiati, Pasquale</mods:namePart>
  </mods:name>
3. <mods:name>
  1. <mods:namePart>Giovannini, Mattia</mods:namePart>
  </mods:name>
4. <mods:name>
  1. <mods:namePart>Agache, Ioana</mods:namePart>
  </mods:name>
5. <mods:name>
  1. <mods:namePart>Akdis, Mübeccel</mods:namePart>
  </mods:name>
6. <mods:name>
  1. <mods:namePart>Alves-Correia, Magna</mods:namePart>
  </mods:name>
7. <mods:name>
  1. <mods:namePart>Antó, Josep M.</mods:namePart>
  </mods:name>
8. <mods:name>
  1. <mods:namePart>Arcolaci, Alessandra</mods:namePart>
  </mods:name>
9. <mods:name>
  1. <mods:namePart>Azkur, Ahmet Kursat</mods:namePart>
  </mods:name>
10. <mods:name>
  1. <mods:namePart>Azkur, Dilek</mods:namePart>
  </mods:name>
11. <mods:name>
  1. <mods:namePart>Beken, Burcin</mods:namePart>
  </mods:name>
12. <mods:name>
  1. <mods:namePart>Boccabella, Cristina</mods:namePart>
  </mods:name>
13. <mods:name>
  1. <mods:namePart>Bousquet, Jean</mods:namePart>
  </mods:name>
14. <mods:name>
  1. <mods:namePart>Breiteneder, Heimo</mods:namePart>
  </mods:name>
15. <mods:name>
  1. <mods:namePart>Carvalho, Daniela</mods:namePart>
  </mods:name>
16. <mods:name>
  1. <mods:namePart>De las Vecillas, Leticia</mods:namePart>
  </mods:name>
17. <mods:name>
  1. <mods:namePart>Diamant, Zuzana</mods:namePart>
  </mods:name>
18. <mods:name>
  1. <mods:namePart>Eguiluz-Gracia, Ibon</mods:namePart>
  </mods:name>
19. <mods:name>
  1. <mods:namePart>Eiwegger, Thomas</mods:namePart>
  </mods:name>
20. <mods:name>
  1. <mods:namePart>Eyerich, Stefanie</mods:namePart>
  </mods:name>
21. <mods:name>
  1. <mods:namePart>Fokkens, Wytske</mods:namePart>
  </mods:name>
22. <mods:name>
  1. <mods:namePart>Gao, Ya-dong</mods:namePart>
  </mods:name>
23. <mods:name>
  1. <mods:namePart>Hannachi, Farah</mods:namePart>
  </mods:name>
24. <mods:name>
  1. <mods:namePart>Johnston, Sebastian L.</mods:namePart>
  </mods:name>
25. <mods:name>
  1. <mods:namePart>Jutel, Marek</mods:namePart>
  </mods:name>
26. <mods:name>
  1. <mods:namePart>Karavelia, Aspasia</mods:namePart>
  </mods:name>
27. <mods:name>
  1. <mods:namePart>Klimek, Ludger</mods:namePart>
  </mods:name>
28. <mods:name>
  1. <mods:namePart>Moya, Beatriz</mods:namePart>
  </mods:name>
29. <mods:name>
  1. <mods:namePart>Nadeau, Kari C.</mods:namePart>
  </mods:name>
30. <mods:name>
  1. <mods:namePart>O'Hehir, Robyn</mods:namePart>
  </mods:name>
31. <mods:name>
  1. <mods:namePart>O'Mahony, Liam</mods:namePart>
  </mods:name>
32. <mods:name>
  1. <mods:namePart>Pfaar, Oliver</mods:namePart>
  </mods:name>
33. <mods:name>
  1. <mods:namePart>Sanak, Marek</mods:namePart>
  </mods:name>
34. <mods:name>
  1. <mods:namePart>Schwarze, Jürgen</mods:namePart>
  </mods:name>
35. <mods:name>
  1. <mods:namePart>Sokolowska, Milena</mods:namePart>
  </mods:name>
36. <mods:name>
  1. <mods:namePart>Torres, María J.</mods:namePart>
  </mods:name>
37. <mods:name>
  1. <mods:namePart>Van de Veen, Willem</mods:namePart>
  </mods:name>
38. <mods:name>
  1. <mods:namePart>Van Zelm, Menno C.</mods:namePart>
  </mods:name>
39. <mods:name>
  1. <mods:namePart>Wang, De Yun</mods:namePart>
  </mods:name>
40. <mods:name>
  1. <mods:namePart>Zhang, Luo</mods:namePart>
  </mods:name>
41. <mods:name>
  1. <mods:namePart>Jiménez-Saiz, Rodrigo</mods:namePart>
  </mods:name>
42. <mods:name>
  1. <mods:namePart>Akdis, Cezmi A.</mods:namePart>
  </mods:name>
43. <mods:extension>
  1. <mods:dateAvailable encoding="iso8601">2021-06-15T10:39:50Z</mods:dateAvailable>
  </mods:extension>
44. <mods:extension>
  1. <mods:dateAccessioned encoding="iso8601">2021-06-15T10:39:50Z</mods:dateAccessioned>
  </mods:extension>
45. <mods:originInfo>
  1. <mods:dateIssued encoding="iso8601">2020</mods:dateIssued>
  </mods:originInfo>
46. <mods:identifier type="issn">0105-4538</mods:identifier>
47. <mods:identifier type="uri">http://hdl.handle.net/10641/2322</mods:identifier>
48. <mods:identifier type="doi">10.1111/all.14449</mods:identifier>
49. <mods:abstract>In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</mods:abstract>
50. <mods:language>
  1. <mods:languageTerm>eng</mods:languageTerm>
  </mods:language>
51. <mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by-nc-nd/3.0/es/</mods:accessCondition>
52. <mods:accessCondition type="useAndReproduction">openAccess</mods:accessCondition>
53. <mods:accessCondition type="useAndReproduction">Atribución-NoComercial-SinDerivadas 3.0 España</mods:accessCondition>
54. <mods:subject>
  1. <mods:topic>Allergy</mods:topic>
  </mods:subject>
55. <mods:subject>
  1. <mods:topic>Coronavirus disease 2019</mods:topic>
  </mods:subject>
56. <mods:subject>
  1. <mods:topic>COVID-19</mods:topic>
  </mods:subject>
57. <mods:subject>
  1. <mods:topic>SARS-CoV-2</mods:topic>
  </mods:subject>
58. <mods:subject>
  1. <mods:topic>Severe acute respiratory syndrome-related coronavirus 2</mods:topic>
  </mods:subject>
59. <mods:titleInfo>
  1. <mods:title>A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</mods:title>
  </mods:titleInfo>
60. <mods:genre>article</mods:genre>
</mods:mods>

ore

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<atom:entry schemaLocation="http://www.w3.org/2005/Atom http://www.kbcafe.com/rss/atom.xsd.xml">
1. <atom:id>http://hdl.handle.net/10641/2322/ore.xml</atom:id>
2. <atom:link href="http://hdl.handle.net/10641/2322" rel="alternate" />
3. <atom:link href="http://hdl.handle.net/10641/2322/ore.xml" rel="http://www.openarchives.org/ore/terms/describes" />
4. <atom:link href="http://hdl.handle.net/10641/2322/ore.xml#atom" rel="self" type="application/atom+xml" />
5. <atom:published>2021-06-15T10:39:50Z</atom:published>
6. <atom:updated>2021-06-15T10:39:50Z</atom:updated>
7. <atom:source>
  1. <atom:generator>DDFV</atom:generator>
  </atom:source>
8. <atom:title>A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</atom:title>
9. <atom:author>
  1. <atom:name>Riggioni, Carmen</atom:name>
  </atom:author>
10. <atom:author>
  1. <atom:name>Comberiati, Pasquale</atom:name>
  </atom:author>
11. <atom:author>
  1. <atom:name>Giovannini, Mattia</atom:name>
  </atom:author>
12. <atom:author>
  1. <atom:name>Agache, Ioana</atom:name>
  </atom:author>
13. <atom:author>
  1. <atom:name>Akdis, Mübeccel</atom:name>
  </atom:author>
14. <atom:author>
  1. <atom:name>Alves-Correia, Magna</atom:name>
  </atom:author>
15. <atom:author>
  1. <atom:name>Antó, Josep M.</atom:name>
  </atom:author>
16. <atom:author>
  1. <atom:name>Arcolaci, Alessandra</atom:name>
  </atom:author>
17. <atom:author>
  1. <atom:name>Azkur, Ahmet Kursat</atom:name>
  </atom:author>
18. <atom:author>
  1. <atom:name>Azkur, Dilek</atom:name>
  </atom:author>
19. <atom:author>
  1. <atom:name>Beken, Burcin</atom:name>
  </atom:author>
20. <atom:author>
  1. <atom:name>Boccabella, Cristina</atom:name>
  </atom:author>
21. <atom:author>
  1. <atom:name>Bousquet, Jean</atom:name>
  </atom:author>
22. <atom:author>
  1. <atom:name>Breiteneder, Heimo</atom:name>
  </atom:author>
23. <atom:author>
  1. <atom:name>Carvalho, Daniela</atom:name>
  </atom:author>
24. <atom:author>
  1. <atom:name>De las Vecillas, Leticia</atom:name>
  </atom:author>
25. <atom:author>
  1. <atom:name>Diamant, Zuzana</atom:name>
  </atom:author>
26. <atom:author>
  1. <atom:name>Eguiluz-Gracia, Ibon</atom:name>
  </atom:author>
27. <atom:author>
  1. <atom:name>Eiwegger, Thomas</atom:name>
  </atom:author>
28. <atom:author>
  1. <atom:name>Eyerich, Stefanie</atom:name>
  </atom:author>
29. <atom:author>
  1. <atom:name>Fokkens, Wytske</atom:name>
  </atom:author>
30. <atom:author>
  1. <atom:name>Gao, Ya-dong</atom:name>
  </atom:author>
31. <atom:author>
  1. <atom:name>Hannachi, Farah</atom:name>
  </atom:author>
32. <atom:author>
  1. <atom:name>Johnston, Sebastian L.</atom:name>
  </atom:author>
33. <atom:author>
  1. <atom:name>Jutel, Marek</atom:name>
  </atom:author>
34. <atom:author>
  1. <atom:name>Karavelia, Aspasia</atom:name>
  </atom:author>
35. <atom:author>
  1. <atom:name>Klimek, Ludger</atom:name>
  </atom:author>
36. <atom:author>
  1. <atom:name>Moya, Beatriz</atom:name>
  </atom:author>
37. <atom:author>
  1. <atom:name>Nadeau, Kari C.</atom:name>
  </atom:author>
38. <atom:author>
  1. <atom:name>O'Hehir, Robyn</atom:name>
  </atom:author>
39. <atom:author>
  1. <atom:name>O'Mahony, Liam</atom:name>
  </atom:author>
40. <atom:author>
  1. <atom:name>Pfaar, Oliver</atom:name>
  </atom:author>
41. <atom:author>
  1. <atom:name>Sanak, Marek</atom:name>
  </atom:author>
42. <atom:author>
  1. <atom:name>Schwarze, Jürgen</atom:name>
  </atom:author>
43. <atom:author>
  1. <atom:name>Sokolowska, Milena</atom:name>
  </atom:author>
44. <atom:author>
  1. <atom:name>Torres, María J.</atom:name>
  </atom:author>
45. <atom:author>
  1. <atom:name>Van de Veen, Willem</atom:name>
  </atom:author>
46. <atom:author>
  1. <atom:name>Van Zelm, Menno C.</atom:name>
  </atom:author>
47. <atom:author>
  1. <atom:name>Wang, De Yun</atom:name>
  </atom:author>
48. <atom:author>
  1. <atom:name>Zhang, Luo</atom:name>
  </atom:author>
49. <atom:author>
  1. <atom:name>Jiménez-Saiz, Rodrigo</atom:name>
  </atom:author>
50. <atom:author>
  1. <atom:name>Akdis, Cezmi A.</atom:name>
  </atom:author>
51. <atom:category label="Aggregation" scheme="http://www.openarchives.org/ore/terms/" term="http://www.openarchives.org/ore/terms/Aggregation" />
52. <atom:category scheme="http://www.openarchives.org/ore/atom/modified" term="2021-06-15T10:39:50Z" />
53. <atom:category label="DSpace Item" scheme="http://www.dspace.org/objectModel/" term="DSpaceItem" />
54. <atom:link href="http://ddfv.ufv.es/bitstream/10641/2322/1/all.14449.pdf" length="2723785" rel="http://www.openarchives.org/ore/terms/aggregates" title="all.14449.pdf" type="application/pdf" />
55. <oreatom:triples>
  1. <rdf:Description about="http://hdl.handle.net/10641/2322/ore.xml#atom">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceItem" />
    2. <dcterms:modified>2021-06-15T10:39:50Z</dcterms:modified>
    </rdf:Description>
  2. <rdf:Description about="http://ddfv.ufv.es/bitstream/10641/2322/1/all.14449.pdf">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceBitstream" />
    2. <dcterms:description>ORIGINAL</dcterms:description>
    </rdf:Description>
  3. <rdf:Description about="http://ddfv.ufv.es/bitstream/10641/2322/2/license_rdf">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceBitstream" />
    2. <dcterms:description>CC-LICENSE</dcterms:description>
    </rdf:Description>
  4. <rdf:Description about="http://ddfv.ufv.es/bitstream/10641/2322/3/license.txt">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceBitstream" />
    2. <dcterms:description>LICENSE</dcterms:description>
    </rdf:Description>
  5. <rdf:Description about="http://ddfv.ufv.es/bitstream/10641/2322/4/all.14449.pdf.txt">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceBitstream" />
    2. <dcterms:description>TEXT</dcterms:description>
    </rdf:Description>
  6. <rdf:Description about="http://ddfv.ufv.es/bitstream/10641/2322/5/all.14449.pdf.jpg">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceBitstream" />
    2. <dcterms:description>THUMBNAIL</dcterms:description>
    </rdf:Description>
  </oreatom:triples>
</atom:entry>

qdc

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<qdc:qualifieddc schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
1. <dc:title>A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</dc:title>
2. <dc:creator>Riggioni, Carmen</dc:creator>
3. <dc:creator>Comberiati, Pasquale</dc:creator>
4. <dc:creator>Giovannini, Mattia</dc:creator>
5. <dc:creator>Agache, Ioana</dc:creator>
6. <dc:creator>Akdis, Mübeccel</dc:creator>
7. <dc:creator>Alves-Correia, Magna</dc:creator>
8. <dc:creator>Antó, Josep M.</dc:creator>
9. <dc:creator>Arcolaci, Alessandra</dc:creator>
10. <dc:creator>Azkur, Ahmet Kursat</dc:creator>
11. <dc:creator>Azkur, Dilek</dc:creator>
12. <dc:creator>Beken, Burcin</dc:creator>
13. <dc:creator>Boccabella, Cristina</dc:creator>
14. <dc:creator>Bousquet, Jean</dc:creator>
15. <dc:creator>Breiteneder, Heimo</dc:creator>
16. <dc:creator>Carvalho, Daniela</dc:creator>
17. <dc:creator>De las Vecillas, Leticia</dc:creator>
18. <dc:creator>Diamant, Zuzana</dc:creator>
19. <dc:creator>Eguiluz-Gracia, Ibon</dc:creator>
20. <dc:creator>Eiwegger, Thomas</dc:creator>
21. <dc:creator>Eyerich, Stefanie</dc:creator>
22. <dc:creator>Fokkens, Wytske</dc:creator>
23. <dc:creator>Gao, Ya-dong</dc:creator>
24. <dc:creator>Hannachi, Farah</dc:creator>
25. <dc:creator>Johnston, Sebastian L.</dc:creator>
26. <dc:creator>Jutel, Marek</dc:creator>
27. <dc:creator>Karavelia, Aspasia</dc:creator>
28. <dc:creator>Klimek, Ludger</dc:creator>
29. <dc:creator>Moya, Beatriz</dc:creator>
30. <dc:creator>Nadeau, Kari C.</dc:creator>
31. <dc:creator>O'Hehir, Robyn</dc:creator>
32. <dc:creator>O'Mahony, Liam</dc:creator>
33. <dc:creator>Pfaar, Oliver</dc:creator>
34. <dc:creator>Sanak, Marek</dc:creator>
35. <dc:creator>Schwarze, Jürgen</dc:creator>
36. <dc:creator>Sokolowska, Milena</dc:creator>
37. <dc:creator>Torres, María J.</dc:creator>
38. <dc:creator>Van de Veen, Willem</dc:creator>
39. <dc:creator>Van Zelm, Menno C.</dc:creator>
40. <dc:creator>Wang, De Yun</dc:creator>
41. <dc:creator>Zhang, Luo</dc:creator>
42. <dc:creator>Jiménez-Saiz, Rodrigo</dc:creator>
43. <dc:creator>Akdis, Cezmi A.</dc:creator>
44. <dc:subject>Allergy</dc:subject>
45. <dc:subject>Coronavirus disease 2019</dc:subject>
46. <dc:subject>COVID-19</dc:subject>
47. <dc:subject>SARS-CoV-2</dc:subject>
48. <dc:subject>Severe acute respiratory syndrome-related coronavirus 2</dc:subject>
49. <dcterms:abstract>In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</dcterms:abstract>
50. <dcterms:dateAccepted>2021-06-15T10:39:50Z</dcterms:dateAccepted>
51. <dcterms:available>2021-06-15T10:39:50Z</dcterms:available>
52. <dcterms:created>2021-06-15T10:39:50Z</dcterms:created>
53. <dcterms:issued>2020</dcterms:issued>
54. <dc:type>article</dc:type>
55. <dc:identifier>0105-4538</dc:identifier>
56. <dc:identifier>http://hdl.handle.net/10641/2322</dc:identifier>
57. <dc:identifier>10.1111/all.14449</dc:identifier>
58. <dc:language>eng</dc:language>
59. <dc:relation>https://onlinelibrary.wiley.com/doi/10.1111/all.14449</dc:relation>
60. <dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights>
61. <dc:rights>openAccess</dc:rights>
62. <dc:rights>Atribución-NoComercial-SinDerivadas 3.0 España</dc:rights>
63. <dc:publisher>Allergy</dc:publisher>
</qdc:qualifieddc>

rdf

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<rdf:RDF schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
1. <ow:Publication about="oai:ddfv.ufv.es:10641/2322">
  1. <dc:title>A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</dc:title>
  2. <dc:creator>Riggioni, Carmen</dc:creator>
  3. <dc:creator>Comberiati, Pasquale</dc:creator>
  4. <dc:creator>Giovannini, Mattia</dc:creator>
  5. <dc:creator>Agache, Ioana</dc:creator>
  6. <dc:creator>Akdis, Mübeccel</dc:creator>
  7. <dc:creator>Alves-Correia, Magna</dc:creator>
  8. <dc:creator>Antó, Josep M.</dc:creator>
  9. <dc:creator>Arcolaci, Alessandra</dc:creator>
  10. <dc:creator>Azkur, Ahmet Kursat</dc:creator>
  11. <dc:creator>Azkur, Dilek</dc:creator>
  12. <dc:creator>Beken, Burcin</dc:creator>
  13. <dc:creator>Boccabella, Cristina</dc:creator>
  14. <dc:creator>Bousquet, Jean</dc:creator>
  15. <dc:creator>Breiteneder, Heimo</dc:creator>
  16. <dc:creator>Carvalho, Daniela</dc:creator>
  17. <dc:creator>De las Vecillas, Leticia</dc:creator>
  18. <dc:creator>Diamant, Zuzana</dc:creator>
  19. <dc:creator>Eguiluz-Gracia, Ibon</dc:creator>
  20. <dc:creator>Eiwegger, Thomas</dc:creator>
  21. <dc:creator>Eyerich, Stefanie</dc:creator>
  22. <dc:creator>Fokkens, Wytske</dc:creator>
  23. <dc:creator>Gao, Ya-dong</dc:creator>
  24. <dc:creator>Hannachi, Farah</dc:creator>
  25. <dc:creator>Johnston, Sebastian L.</dc:creator>
  26. <dc:creator>Jutel, Marek</dc:creator>
  27. <dc:creator>Karavelia, Aspasia</dc:creator>
  28. <dc:creator>Klimek, Ludger</dc:creator>
  29. <dc:creator>Moya, Beatriz</dc:creator>
  30. <dc:creator>Nadeau, Kari C.</dc:creator>
  31. <dc:creator>O'Hehir, Robyn</dc:creator>
  32. <dc:creator>O'Mahony, Liam</dc:creator>
  33. <dc:creator>Pfaar, Oliver</dc:creator>
  34. <dc:creator>Sanak, Marek</dc:creator>
  35. <dc:creator>Schwarze, Jürgen</dc:creator>
  36. <dc:creator>Sokolowska, Milena</dc:creator>
  37. <dc:creator>Torres, María J.</dc:creator>
  38. <dc:creator>Van de Veen, Willem</dc:creator>
  39. <dc:creator>Van Zelm, Menno C.</dc:creator>
  40. <dc:creator>Wang, De Yun</dc:creator>
  41. <dc:creator>Zhang, Luo</dc:creator>
  42. <dc:creator>Jiménez-Saiz, Rodrigo</dc:creator>
  43. <dc:creator>Akdis, Cezmi A.</dc:creator>
  44. <dc:subject>Allergy</dc:subject>
  45. <dc:subject>Coronavirus disease 2019</dc:subject>
  46. <dc:subject>COVID-19</dc:subject>
  47. <dc:subject>SARS-CoV-2</dc:subject>
  48. <dc:subject>Severe acute respiratory syndrome-related coronavirus 2</dc:subject>
  49. <dc:description>In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</dc:description>
  50. <dc:date>2021-06-15T10:39:50Z</dc:date>
  51. <dc:date>2021-06-15T10:39:50Z</dc:date>
  52. <dc:date>2020</dc:date>
  53. <dc:type>article</dc:type>
  54. <dc:identifier>0105-4538</dc:identifier>
  55. <dc:identifier>http://hdl.handle.net/10641/2322</dc:identifier>
  56. <dc:identifier>10.1111/all.14449</dc:identifier>
  57. <dc:language>eng</dc:language>
  58. <dc:relation>https://onlinelibrary.wiley.com/doi/10.1111/all.14449</dc:relation>
  59. <dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights>
  60. <dc:rights>openAccess</dc:rights>
  61. <dc:rights>Atribución-NoComercial-SinDerivadas 3.0 España</dc:rights>
  62. <dc:publisher>Allergy</dc:publisher>
  </ow:Publication>
</rdf:RDF>

xoai

Descargar XML

<?xml version="1.0" encoding="UTF-8" ?>

<metadata schemaLocation="http://www.lyncode.com/xoai http://www.lyncode.com/xsd/xoai.xsd">
1. <element name="dc">
  1. <element name="contributor">
    1. <element name="author">
      1. <element name="none">
        <field name="value">Riggioni, Carmen</field>
        <field name="authority">1f3cd91c-9e10-4a07-870c-a30a7d02e74b</field>
        <field name="confidence">600</field>
        <field name="value">Comberiati, Pasquale</field>
        <field name="authority">ee4f6d96-51a5-4c1f-8953-5f3ec4b57e02</field>
        <field name="confidence">600</field>
        <field name="value">Giovannini, Mattia</field>
        <field name="authority">4bd0c581-c561-451a-b392-d0874db75db9</field>
        <field name="confidence">600</field>
        <field name="value">Agache, Ioana</field>
        <field name="authority">09de94e0-8daa-4c6f-81b4-cc207418ff74</field>
        <field name="confidence">600</field>
        <field name="value">Akdis, Mübeccel</field>
        <field name="authority">69412ee0-4967-4c5f-a732-9d7431c9d221</field>
        <field name="confidence">600</field>
        <field name="value">Alves-Correia, Magna</field>
        <field name="authority">1bd1619b-36d8-41d3-b058-ecbaa3b5676e</field>
        <field name="confidence">600</field>
        <field name="value">Antó, Josep M.</field>
        <field name="authority">c74b2ce6-2855-4dd8-bf22-7d6243cb4bb7</field>
        <field name="confidence">600</field>
        <field name="value">Arcolaci, Alessandra</field>
        <field name="authority">ab467e8b-c6c8-4017-ac81-a374ceb4bd5b</field>
        <field name="confidence">600</field>
        <field name="value">Azkur, Ahmet Kursat</field>
        <field name="authority">e10531c7-43d5-43d5-b940-283ce608e2f4</field>
        <field name="confidence">600</field>
        <field name="value">Azkur, Dilek</field>
        <field name="authority">a643501e-43d3-4314-b8df-df131a20c0dc</field>
        <field name="confidence">600</field>
        <field name="value">Beken, Burcin</field>
        <field name="authority">7d78f2c1-cae2-4c49-8fd2-27b70a938746</field>
        <field name="confidence">600</field>
        <field name="value">Boccabella, Cristina</field>
        <field name="authority">8268f781-d7e0-48b0-b04e-21f06947d8b1</field>
        <field name="confidence">600</field>
        <field name="value">Bousquet, Jean</field>
        <field name="authority">478904c2-695f-4832-b5a4-a5492f2f4017</field>
        <field name="confidence">600</field>
        <field name="value">Breiteneder, Heimo</field>
        <field name="authority">25f637ac-1cdd-4fa3-9096-8a7f18144470</field>
        <field name="confidence">600</field>
        <field name="value">Carvalho, Daniela</field>
        <field name="authority">b69efa5c-e57d-427d-8928-11d3e5bc1c4f</field>
        <field name="confidence">600</field>
        <field name="value">De las Vecillas, Leticia</field>
        <field name="authority">6fa0b071-7ffb-4779-a2ad-da564a0b21bd</field>
        <field name="confidence">600</field>
        <field name="value">Diamant, Zuzana</field>
        <field name="authority">3b9ea73e-a35e-480a-8afe-c368a18dea5e</field>
        <field name="confidence">600</field>
        <field name="value">Eguiluz-Gracia, Ibon</field>
        <field name="authority">d17f943d-9c05-4c07-bdec-d9a604edec52</field>
        <field name="confidence">600</field>
        <field name="value">Eiwegger, Thomas</field>
        <field name="authority">6deb7e44-67a2-4922-afbb-cd09ce0a2896</field>
        <field name="confidence">600</field>
        <field name="value">Eyerich, Stefanie</field>
        <field name="authority">493091ae-31cb-4c04-9905-62411aec73fd</field>
        <field name="confidence">600</field>
        <field name="value">Fokkens, Wytske</field>
        <field name="authority">1328cfb8-b64c-4bec-824b-39a49a707542</field>
        <field name="confidence">600</field>
        <field name="value">Gao, Ya-dong</field>
        <field name="authority">8981f3db-c05b-466e-9c01-169cdca39d60</field>
        <field name="confidence">600</field>
        <field name="value">Hannachi, Farah</field>
        <field name="authority">a6c524aa-4248-40ed-b4b7-91c1e930afbe</field>
        <field name="confidence">600</field>
        <field name="value">Johnston, Sebastian L.</field>
        <field name="authority">e3911610-4d90-4798-9653-db6760124fa0</field>
        <field name="confidence">600</field>
        <field name="value">Jutel, Marek</field>
        <field name="authority">33d62bae-7001-4ce3-bd00-f0edf123bc80</field>
        <field name="confidence">600</field>
        <field name="value">Karavelia, Aspasia</field>
        <field name="authority">8e05c3f9-3736-457f-82d9-b4fbe70a8efb</field>
        <field name="confidence">600</field>
        <field name="value">Klimek, Ludger</field>
        <field name="authority">acf05571-4fc5-45c3-92a3-ec1331c9be22</field>
        <field name="confidence">600</field>
        <field name="value">Moya, Beatriz</field>
        <field name="authority">4749920d-be53-4f1c-8b55-00b65ed154ca</field>
        <field name="confidence">600</field>
        <field name="value">Nadeau, Kari C.</field>
        <field name="authority">de71bbb8-537a-4451-a128-00f9d2bbbae2</field>
        <field name="confidence">600</field>
        <field name="value">O'Hehir, Robyn</field>
        <field name="authority">75705d12-f79e-460f-878e-8660dc049a91</field>
        <field name="confidence">600</field>
        <field name="value">O'Mahony, Liam</field>
        <field name="authority">709e3101-f7eb-4661-b6de-eac110c71bf0</field>
        <field name="confidence">600</field>
        <field name="value">Pfaar, Oliver</field>
        <field name="authority">2ad13a86-9e46-4ed0-986c-abb7aecbebb7</field>
        <field name="confidence">600</field>
        <field name="value">Sanak, Marek</field>
        <field name="authority">75da5432-6a86-43b1-862d-7a41fdac1788</field>
        <field name="confidence">600</field>
        <field name="value">Schwarze, Jürgen</field>
        <field name="authority">8253fd73-1b00-47ef-964e-f8db090aafb7</field>
        <field name="confidence">600</field>
        <field name="value">Sokolowska, Milena</field>
        <field name="authority">187d0984-a5dd-48c6-ad10-02807a8cd4dd</field>
        <field name="confidence">600</field>
        <field name="value">Torres, María J.</field>
        <field name="authority">87e7160e-f50c-4c14-87db-8e33a65ddd17</field>
        <field name="confidence">600</field>
        <field name="value">Van de Veen, Willem</field>
        <field name="authority">3f993b14-1942-4856-bf28-12e9d79242dd</field>
        <field name="confidence">600</field>
        <field name="value">Van Zelm, Menno C.</field>
        <field name="authority">7593d05b-10d4-4534-9ea5-1c7d83a65ef0</field>
        <field name="confidence">600</field>
        <field name="value">Wang, De Yun</field>
        <field name="authority">12096dd1-93cb-4a6f-b0e0-ee41f34308b2</field>
        <field name="confidence">600</field>
        <field name="value">Zhang, Luo</field>
        <field name="authority">d326595f-eeb7-42a4-9c74-6ea227398e49</field>
        <field name="confidence">600</field>
        <field name="value">Jiménez-Saiz, Rodrigo</field>
        <field name="authority">a6b6771f-0ac3-4a44-ab4e-7862e875d21f</field>
        <field name="confidence">600</field>
        <field name="value">Akdis, Cezmi A.</field>
        <field name="authority">888fc87b-bf4a-4dd7-8150-bcc5390229a6</field>
        <field name="confidence">600</field>
        </element>
      </element>
    </element>
  2. <element name="date">
    1. <element name="accessioned">
      1. <element name="none">
        <field name="value">2021-06-15T10:39:50Z</field>
        </element>
      </element>
    2. <element name="available">
      1. <element name="none">
        <field name="value">2021-06-15T10:39:50Z</field>
        </element>
      </element>
    3. <element name="issued">
      1. <element name="none">
        <field name="value">2020</field>
        </element>
      </element>
    </element>
  3. <element name="identifier">
    1. <element name="issn">
      1. <element name="spa">
        <field name="value">0105-4538</field>
        </element>
      </element>
    2. <element name="uri">
      1. <element name="none">
        <field name="value">http://hdl.handle.net/10641/2322</field>
        </element>
      </element>
    3. <element name="doi">
      1. <element name="spa">
        <field name="value">10.1111/all.14449</field>
        </element>
      </element>
    </element>
  4. <element name="description">
    1. <element name="abstract">
      1. <element name="spa">
        <field name="value">In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.</field>
        </element>
      </element>
    2. <element name="version">
      1. <element name="spa">
        <field name="value">post-print</field>
        </element>
      </element>
    3. <element name="extent">
      1. <element name="spa">
        <field name="value">2,59 MB</field>
        </element>
      </element>
    </element>
  5. <element name="language">
    1. <element name="iso">
      1. <element name="spa">
        <field name="value">eng</field>
        </element>
      </element>
    </element>
  6. <element name="publisher">
    1. <element name="spa">
      1. <field name="value">Allergy</field>
      </element>
    </element>
  7. <element name="rights">
    1. <element name="*">
      1. <field name="value">Atribución-NoComercial-SinDerivadas 3.0 España</field>
      </element>
    2. <element name="uri">
      1. <element name="*">
        <field name="value">http://creativecommons.org/licenses/by-nc-nd/3.0/es/</field>
        </element>
      </element>
    3. <element name="accessRights">
      1. <element name="spa">
        <field name="value">openAccess</field>
        </element>
      </element>
    </element>
  8. <element name="subject">
    1. <element name="spa">
      1. <field name="value">Allergy</field>
      2. <field name="value">Coronavirus disease 2019</field>
      3. <field name="value">COVID-19</field>
      4. <field name="value">SARS-CoV-2</field>
      5. <field name="value">Severe acute respiratory syndrome-related coronavirus 2</field>
      </element>
    </element>
  9. <element name="title">
    1. <element name="spa">
      1. <field name="value">A compendium answering 150 questions on COVID-19 and SARS-CoV-2.</field>
      </element>
    </element>
  10. <element name="type">
    1. <element name="spa">
      1. <field name="value">article</field>
      </element>
    </element>
  11. <element name="relation">
    1. <element name="publisherversion">
      1. <element name="spa">
        <field name="value">https://onlinelibrary.wiley.com/doi/10.1111/all.14449</field>
        </element>
      </element>
    </element>
  </element>
2. <element name="bundles">
  1. <element name="bundle">
    1. <field name="name">ORIGINAL</field>
    2. <element name="bitstreams">
      1. <element name="bitstream">
        <field name="name">all.14449.pdf</field>
        <field name="originalName">all.14449.pdf</field>
        <field name="description" />
        <field name="format">application/pdf</field>
        <field name="size">2723785</field>
        <field name="url">http://ddfv.ufv.es/bitstream/10641/2322/1/all.14449.pdf</field>
        <field name="checksum">f885282ebbc51a2d43fb951d61d34f98</field>
        <field name="checksumAlgorithm">MD5</field>
        <field name="sid">1</field>
        </element>
      </element>
    </element>
  2. <element name="bundle">
    1. <field name="name">CC-LICENSE</field>
    2. <element name="bitstreams">
      1. <element name="bitstream">
        <field name="name">license_rdf</field>
        <field name="originalName">license_rdf</field>
        <field name="format">application/rdf+xml; charset=utf-8</field>
        <field name="size">811</field>
        <field name="url">http://ddfv.ufv.es/bitstream/10641/2322/2/license_rdf</field>
        <field name="checksum">4d01a8abc68801ab758ec8c2c04918c3</field>
        <field name="checksumAlgorithm">MD5</field>
        <field name="sid">2</field>
        </element>
      </element>
    </element>
  3. <element name="bundle">
    1. <field name="name">LICENSE</field>
    2. <element name="bitstreams">
      1. <element name="bitstream">
        <field name="name">license.txt</field>
        <field name="originalName">license.txt</field>
        <field name="format">text/plain; charset=utf-8</field>
        <field name="size">2418</field>
        <field name="url">http://ddfv.ufv.es/bitstream/10641/2322/3/license.txt</field>
        <field name="checksum">8b6e3a0bc6a1ca51936267b0e6e4740c</field>
        <field name="checksumAlgorithm">MD5</field>
        <field name="sid">3</field>
        </element>
      </element>
    </element>
  4. <element name="bundle">
    1. <field name="name">TEXT</field>
    2. <element name="bitstreams">
      1. <element name="bitstream">
        <field name="name">all.14449.pdf.txt</field>
        <field name="originalName">all.14449.pdf.txt</field>
        <field name="description">Extracted text</field>
        <field name="format">text/plain</field>
        <field name="size">199857</field>
        <field name="url">http://ddfv.ufv.es/bitstream/10641/2322/4/all.14449.pdf.txt</field>
        <field name="checksum">8d3257013c06de42b96b9decb9264253</field>
        <field name="checksumAlgorithm">MD5</field>
        <field name="sid">4</field>
        </element>
      </element>
    </element>
  5. <element name="bundle">
    1. <field name="name">THUMBNAIL</field>
    2. <element name="bitstreams">
      1. <element name="bitstream">
        <field name="name">all.14449.pdf.jpg</field>
        <field name="originalName">all.14449.pdf.jpg</field>
        <field name="description">Generated Thumbnail</field>
        <field name="format">image/jpeg</field>
        <field name="size">1769</field>
        <field name="url">http://ddfv.ufv.es/bitstream/10641/2322/5/all.14449.pdf.jpg</field>
        <field name="checksum">c93e48f3813384c18df5f4757e0a961e</field>
        <field name="checksumAlgorithm">MD5</field>
        <field name="sid">5</field>
        </element>
      </element>
    </element>
  </element>
3. <element name="others">
  1. <field name="handle">10641/2322</field>
  2. <field name="identifier">oai:ddfv.ufv.es:10641/2322</field>
  3. <field name="lastModifyDate">2021-06-16 02:00:23.628</field>
  </element>
4. <element name="repository">
  1. <field name="name">DDFV</field>
  2. <field name="mail">dspace@ufv.es</field>
  </element>
5. <element name="license">
  1. <field name="bin">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</field>
  </element>
</metadata>